Ochratoxin A reduces aflatoxin B1 induced DNA damage detected by the comet assay in Hep G2 cells

Food and Chemical Toxicology

Volumn 49, Issue 11, 2011, Pages 2883-2889

  Corcuera, L A ^a   Arbillaga, L ^a   Vettorazzi, A ^a   Azqueta, A ^a   Lopez de Cerain A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Aflatoxin B1; Combined genotoxicity; Comet assay; Hep G2; Mycotoxins; Ochratoxin A

Indexed keywords

AFLATOXIN B1; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; MYCOTOXIN; OCHRATOXIN; REACTIVE OXYGEN METABOLITE; RESTRICTION ENDONUCLEASE;

ARTICLE; CELL STRAIN HEPG2; CELL SURVIVAL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; GENOTOXICITY; HUMAN; HUMAN CELL; IC 50; TOXICITY TESTING;

AFLATOXIN B1; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; OCHRATOXINS; REACTIVE OXYGEN SPECIES;

EID: 80052834802     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.07.029     Document Type: Article

References (49)

1. Arbillaga L., Azqueta A., Ezpeleta O., Lopez de Cerain A. Oxidative DNA damage induced by ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity. Mutagenesis 2007, 22:35-42.
2. Arbillaga L., Ezpeleta O., Lopez de Cerain A. ¿Es la Ocratoxina A una micotoxina mutagénica (Is the Ochratoxin A a mutagenic mycotoxine?). Revista de Toxicología 2004, 21:1-10.
3. Bedard L.L., Massey T.E. Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 2006, 241:174-183.
4. Binder E.M., Tan L.M., Chin L.J., Handl J., Richard J. Worldwide occurrence of mycotoxins in commodities, feeds and feed ingredients. Anim. Feed Sci. Technol. 2007, 137:265-282.
5. Brunborg, G., 2008. Spreadsheet to calculate voltages and currents in an electrophoresis tank. Available from: http://comics.vitamib.com/electrophoresis-physics.
6. Collins A.R., Oscoz A.A., Brunborg G., Gaivao I., Giovannelli L., Kruszewski M., Smith C.C., Stetina R. The comet assay: topical issues. Mutagenesis 2008, 23:143-151.
7. Collins A.R. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol. Biotechnol. 2004, 26:249-261.
8. Collins A.R., Dusinska M. Oxidation of cellular DNA measured with the comet assay. Methods Mol. Biol. 2002, 186:147-159.
9. Collins A.R., Dusinska M., Horvathova E., Munro E., Savio M., Stetina R. Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis 2001, 16:297-301.
10. Collins A.R., Dobson V.L., Dusinska M., Kennedy G., Stetina R. The comet assay: what can it really tell us?. Mutat. Res. 1997, 375:183-193.
11. Costa S., Utan A., Cervellati R., Speroni E., Guerra M.C. Catechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1). Food Chem. Toxicol. 2007, 45:1910-1917.
12. Creppy E.E., Chiarappa P., Baudrimont I., Borracci P., Moukha S., Carratu M.R. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?. Toxicology 2004, 201:115-123.
13. EFSA, 2007. Opinion of the Scientific Panel on Contaminats in the Food Chain on a request from the Commission related to the potential increase of consumer health risk by a possible increase of the existing maximun levels for Aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J. 446, 1-127.
14. EFSA, 2006. Opinion of the scientific panel on contaminants in the Food Chain on a request from the commission related to Ochratoxin A in food. EFSA J. 365, 1-56.
15. Ehrlich V., Darroudi F., Uhl M., Steinkellner H., Gann M., Majer B.J., Eisenbauer M., Knasmuller S. Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem. Toxicol. 2002, 40:1085-1090.
16. El Golli E., Hassen W., Bouslimi A., Bouaziz C., Ladjimi M.M., Bacha H. Induction of Hsp70 in Vero cells in response to mycotoxins cytoprotection by sub-lethal heat shock and by Vitamin E. Toxicol. Lett. 2006, 166:122-130.
17. El Golli-Bennour E., Kouidhi B., Bouslimi A., Abid-Essefi S., Hassen W., Bacha H. Cytotoxicity and genotoxicity induced by aflatoxin B1, ochratoxin A, and their combination in cultured Vero cells. J. Biochem. Mol. Toxicol. 2010, 24:42-50.
18. European Commission, 2006. Commission Regulation (EC) No. 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in foodstuffs (Text with EEA relevance). OJ L 364, 20.12.06, pp. 5-24.
19. European Commission, 2002. Commission Regulation (EC) No. 472/2002 of 12 March 2002 amending Regulation (EC) No 466/2001 setting maximum levels for certain contaminants in foodstuffs (Text with EEA relevance). L 75/18.
20. Hassen W., El Golli E., Baudrimont I., Mobio A.T., Ladjimi M.M., Creppy E.E., Bacha H. Cytotoxicity and Hsp70 induction in Hep G2 cells in response to zearalenone and cytoprotection by sub-lethal heat shock. Toxicology 2005, 207:293-301.
21. Heussner A.H., Dietrich D.R., O'Brien E. In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells. Toxicol. In Vitro 2006, 20:332-341.
22. IARC, 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene, vol. 82, p. 590.
23. IARC, 1993. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, vol. 56, p. 33.
24. IARC, 1987. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1-42(Suppl. 7), p. 440.
25. Knasmuller S., Parzefall W., Sanyal R., Ecker S., Schwab C., Uhl M., Mersch-Sundermann V., Williamson G., Hietsch G., Langer T., Darroudi F., Natarajan A.T. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res. 1998, 402:185-202.
26. Mally, A., Dekant, W., 2005. DNA adduct formation by ochratoxin A: review of the available evidence. Food Addit. Contam. 22(Suppl. 1), 65-74.
27. Mally A., Pepe G., Ravoori S., Fiore M., Gupta R.C., Dekant W., Mosesso P. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 2005, 18:1253-1261.
28. Mally A., Zepnik H., Wanek P., Eder E., Dingley K., Ihmels H., Volkel W., Dekant W. Ochratoxin A: lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 2004, 17:234-242.
29. McKean C., Tang L., Tang M., Billam M., Wang Z., Theodorakis C.W., Kendall R.J., Wang J.S. Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells. Food Chem. Toxicol. 2006, 44:868-876.
30. McKean C., Tang L., Billam M., Tang M., Theodorakis C., Kendall R., Wang J. Comparative acute and combinative toxicity of aflatoxin B1 and T-2 toxin in animals and immortalized human cell lines. J. Appl. Toxicol. 2006, 26:139-147.
31. McLean M., Dutton M.F. Cellular interactions and metabolism of aflatoxin: An update. Pharm. Ther. 1995, 65:163-192.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
33. OECD Guideline for the testing of chemicals, Number 473. Adopted 21st July 1997. In vitro Mammalian Chromosome Aberration Tests.
34. OECD Guideline for the testing of chemicals, Number 487. Adopted 22nd July 2010. In vitro Mammalian Cell Micronucleus Test.
35. Otto M., Hansen S.H., Dalgaard L., Dubois J., Badolo L. Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity. Cell Biol. Toxicol. 2008, 24:87-99.
36. Pfuhler, S., Fellows, M., van Benthem, J., Corvi, R., Curren, R., Dearfield, K., Fowler, P., Frtschl, R., Elhajouji, A., Le Hgarat, L., Kasamatsu, T., Kojima, H., Oudraogo, G., Scott, A., Speit, G., 2011. In vitro genotoxicity test approaches with better predictivity: Summary of an IWGT workshop. Mutat. Res. doi:. doi:10.1016/j.mrgentox.2011.03.01.
37. Ringot D., Chango A., Schneider Y.J., Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159:18-46.
38. Sava V., Velasquez A., Song S., Sanchez-Ramos J. Adult hippocampal neural stem/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin-A. Toxicol. Sci. 2007, 98:187-197.
39. Sava V., Reunova O., Velasquez A., Harbison R., Sanchez-Ramos J. Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 2006, 27:82-92.
40. Sava V., Reunova O., Velasquez A., Sanchez-Ramos J. Can low level exposure to ochratoxin-A cause Parkinsonism?. J. Neurol. Sci. 2006, 249:68-75.
41. Sedmíková M., Reisnerová H., Dufková Z., Bárta I., Jílek F. Potential hazard of simultaneous occurrence of aflatoxin B1 and ochratoxin A. Veterinarni Medicina 2001, 46:169-174.
42. Simarro Doorten Y.S., Nijmeijer S., de Nijs-Tjon L., Fink-Gremmels J. Metabolism-mediated Ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay. Food Chem. Toxicol. 2006, 44:261-270.
43. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
44. Smela M.E., Hamm M.L., Henderson P.T., Harris C.M., Harris T.M., Essigmann J.M. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 2002, 99:6655-6660.
45. Speijers G.J.A. Combined toxic effects of mycotoxins. Toxicol. Lett. 2004, 153:91.
46. Turesky R.J. Perspective: ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 2005, 18:1082-1090.
47. Uhl M., Helma C., Knasmuller S. Single-cell gel electrophoresis assays with human-derived hepatoma (Hep G2) cells. Mutat. Res. 1999, 441:215-224.
48. Urrego Novoa J.R., Diaz G.J. Aflatoxins and its mechanisms of toxicity in hepatic cancer. Rev. Fac. Med. Una. 2006, 54:108-116.
49. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.